
- 10 mg single vial
- Tracked U.S. fulfillment
- Research use only
CJC-1295 Without DAC + Ipamorelin Blend
Laboratory research procurement
CJC-1295 without DAC + Ipamorelin: 5 mg + 5 mg
This single-vial research blend contains labeled amounts of 5 mg CJC-1295 without DAC and 5 mg Ipamorelin, for 10 mg total. Without DAC is also described as no DAC; a CJC-1295 with-DAC listing is not the same catalog specification. Compare both component names and amounts, rather than the combined vial weight alone. Review documentation for the exact blend and supplied lot before laboratory procurement.
Price before account discounts$69.00Standard VIP · 5% off $65.55Sign in for your eligible price. First-order or WIRED offers apply instead when eligible; offers do not stack.
Up to $250 savings. Standard VIP: 5% ongoing. WIRED members: 15% ongoing. Sign in to apply your eligible offer; offers do not stack.
Certificate of Analysis history
Laboratory report history
CJC-1295 without DAC + Ipamorelin
- Catalog SKU
- CP10
- Batch
- 3
- Laboratory task
- 113516
- Sample received
- March 16, 2026
Match the catalog SKU, batch, and task number before relying on this report for research documentation.
What is CJC-1295 Without DAC + Ipamorelin Blend?
This 10 mg total research blend is labeled as containing 5 mg CJC-1295 without DAC and 5 mg Ipamorelin. Laboratory evaluation should confirm the identity and declared amount of each component and distinguish GHRHR- and GHSR1a-related assay readouts.
- Classification
- dual-peptide receptor-assay research blend
- Format
- 10 mg total lyophilized powder vial (5 mg CJC-1295 without DAC + 5 mg Ipamorelin)
- Documentation
- Review current COA records
Research use only. Not for human or animal consumption. Catalog classification does not establish identity, suitability, safety, efficacy, or an experimental outcome.
Research overview
Product Overview
This 10 mg total research blend is labeled as containing 5 mg CJC-1295 without DAC and 5 mg Ipamorelin. Laboratory evaluation should confirm the identity and declared amount of each component and distinguish GHRHR- and GHSR1a-related assay readouts.
What Is This Compound?
CJC-1295 Without DAC + Ipamorelin Blend is classified in this catalog as a dual-peptide receptor-assay research blend. Its identity should be evaluated from the label, batch documentation, analytical method, and relevant primary literature rather than from consumer-use descriptions.
Research Classification
Dual-peptide receptor-assay research blend. Catalog category: Growth Hormone Axis.
Molecular and scientific context
Mechanism Overview
Mechanistic investigation of CJC-1295 Without DAC + Ipamorelin Blend should focus on experimentally measured molecular interactions, validated targets, pathway readouts, and model-specific conditions. A catalog classification is not evidence of a biological outcome; researchers should confirm target engagement in primary literature and within their own validated assay.
Scientific Background
Literature review for CJC-1295 Without DAC + Ipamorelin Blend should distinguish the exact molecular entity from related compounds and should record the experimental model, concentration, controls, endpoints, and analytical method.
Chemical Characteristics
The exact molecular formula, mass, sequence, counterion, hydration state, and solvent compatibility can depend on the supplied form. Use the current label and matching batch documentation as the controlling product record. Do not infer chemical identity from the product name alone.
Research applications and interests
Research Applications
Laboratory work involving CJC-1295 Without DAC + Ipamorelin Blend may include analytical identity testing, purity assessment, method development, stability evaluation, and controlled mechanistic investigation relevant to its research classification.
Research Interests
- Component-specific receptor-assay research
- Multi-analyte identity assessment
- Declared-amount and batch-record review
- Controlled comparative assay design
Research Notes
- Define the exact molecular entity or blend components before selecting literature.
- Confirm the selected format before procurement and analytical planning.
- Match every analytical report to the exact product and batch identifier.
Research specifications
Research Specifications
| Catalog compound | CJC-1295 Without DAC + Ipamorelin Blend |
|---|---|
| Research classification | dual-peptide receptor-assay research blend |
| Catalog format | 10 mg total lyophilized powder vial (5 mg CJC-1295 without DAC + 5 mg Ipamorelin) |
| Catalog category | Growth Hormone Axis |
Catalog-level record. Match any lot-specific identity, reported purity, test date, and analytical result to the corresponding COA before relying on it.
Quality control and documentation
Quality Control
A defensible quality review for CJC-1295 Without DAC + Ipamorelin Blend should separate identity from purity and should verify that every report maps to the received batch. Depending on the material, useful methods may include mass spectrometry, chromatographic purity analysis, water or solvent testing, and other fit-for-purpose assays.
Certificate of Analysis
Review the COA library before ordering and again after receipt. Match the product name, stated amount, batch or lot identifier, laboratory, analytical method, result, and test date. The absence of a matching report should not be interpreted as independent verification.
Batch Verification Checklist
- Product identity and supplied form match the label.
- Batch or lot identifier matches the received vial.
- Analytical method is appropriate for the reported result.
- Report date, laboratory identity, and document integrity are clear.
- Purity, identity, and quantity are treated as separate measurements.
Related research and scientific resources
Related Compounds
Documentation and Category Resources
- Browse this product category
- COA & Lab Reports
- How to Read a COA
- Research Education
- Growth hormone axis research guide
Suggested Glossary Links
External Scientific References
Frequently asked questions
What is CJC-1295 Without DAC + Ipamorelin Blend?
CJC-1295 Without DAC + Ipamorelin Blend is cataloged as a dual-peptide receptor-assay research blend. The listing is intended for laboratory identification, analytical planning, and controlled research workflows only.
What documentation should be reviewed for CJC-1295 Without DAC + Ipamorelin Blend?
Review the current product label and any matching Certificate of Analysis. Confirm the product name, stated amount, batch or lot identifier, test method, laboratory, and report date.
How should CJC-1295 Without DAC + Ipamorelin Blend be handled?
Use qualified laboratory personnel, an approved protocol, calibrated equipment, and the storage conditions on the current label or batch documentation. This catalog does not provide personal-use or administration instructions.
Is CJC-1295 Without DAC + Ipamorelin Blend supplied for research use only?
Yes. It is supplied strictly for laboratory research and analytical workflows and is not intended for human or animal consumption.
Where can I find scientific literature about CJC-1295 Without DAC + Ipamorelin Blend?
Use primary scientific databases such as PubMed and PubChem, and verify that the identity, form, and experimental model in a publication match the material under review.
Research Use Only. Supplied strictly for laboratory research and analytical workflows. Not for human or animal consumption.
